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Abstract
Background: Management of benign tracheal stenosis (BTS) varies with the type and extent of the disease and
influenced by the patient’s age and general health status, hence we sought to investigate the long-term outcome
of patients with BTS that underwent minimally invasive bronchoscopic treatment.
Methods: Patients with symptomatic BTS were treated with flexible bronchoscopy therapeutic modalities that
included the following: balloon dilatation, laser photo-resection, self-expanding metal stent placement, and High-
dose rate endobronchial brachytherapy used in cases of refractory stent-related granulation tissue formation.
Results: A total of 115 patients with BTS and various cardiac and respiratory co-morbidities with a mean age of 61
(range 40-88)were treated between January 2001 and January 2009. The underlining etiologies for BTS were post -
endotracheal intubation (N = 76) post-tracheostomy (N = 30), Wegener’s granulomatosis (N = 2), sarcoidosis (N =
2), amyloidosis (N = 2) and idiopathic BTS (N = 3). The modalities used were: balloon dilatation and laser treatment
(N = 98). Stent was placed in 33 patients of whom 28 also underwent brachytherapy. Complications were minor
and mostly included granulation tissue formation. The overall success rate was 87%. Over a median follow-up of 51
months (range 10-100 months), 30 patients (26%) died, mostly due to exacerbation of their underlying conditions.
Conclusions: BTS in elderly patients with co-morbidities can be safely and effectively treated by flexible
bronchoscopic treatment modalities. The use of HDR brachytherapy to treat granulation tissue formation following
successful airway restoration is promising.
Introduction
The most common etiology for acquired benign tracheal
stenosis (BTS) is tracheal intubation (even for a short per-
iod of time) or tracheostomy [1,2]. Acquired BTS may also
occur due to traumatic intubation, laryngeal trauma due
to previous laryngeal surgery and prior surgery for upper
airway papillomatosis. BTS can also be accidental as a
result of inhalational (thermal or caustic) injury or compli-
cating cervical trauma (either blunt or penetrating). Rare
causes for BTS include autoimmune diseases as well as
inflammatory diseases such as Wegener’s granulomatosis,
sarcoidosis and systemic lupus erythromatosis [3].
The management of BTS varies with the type and
extent of the disease and depends upon the age and co-
morbidities of the patient [4]. The optimal therapeutic
approach for BTS is surgical reconstruction [5,6]. How-
ever many elderly patient with underlying conditions are
inoperable and require endobronchial palliation. Treat-
ment options include laser ablation of granulation tissue,
electro coagulation, mechanical dilatation, and/or stent
placement into the affected area [7-15].
The aim of the current report was to review our
experience in treating BTS secondary to various etiolo-
gies, review the treatment strategies used, and evaluate
long-term success rates and complications.
Patients and methods
Our institute serves as a regional referral center for
interventional bronchoscopy procedures. We retrospec-
tively analyzed the medical records of all patients who
were refereed to our institute for evaluation and man-
agement of symptomatic BTS between January 2001 and
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obtained, but specific informed consent was not
required for this retrospective study. Informed consent
for each bronchoscopy was obtained prior to the
procedure.
Each patient underwent a standard pre-operative
assessment, including physical examination, routine
laboratory tests, spirometry, chest radiography and com-
puted tomography of the chest. An initial diagnostic
flexible bronchoscopy was performed for each patient to
identify the type, location and severity of the stenosis.
The degree of stenosis was estimated visually. Flexible
bronchoscopy was performed under conscious sedation
with midazolam (1-10 mg) and alfentanyl (0. 5 mg-1.5
mg), in the bronchoscopy suite and nder Spontaneous
ventilation with supplemental O2 through nasal canula.
The equipment used included flexible bronchoscopes
(Pentax Co. Tokyo, Japan or Olympus Co. Tokyo,
Japan). For web-like stenoses a recommended mucosal
sparring technique with radial incisions followed by air-
way dilatation using balloon bronchoplasty as described
by Mehta [9]. For stenosis produced by granulation tis-
sue formation around the tracheal stoma, photocoagula-
tion with Nd:YAG laser was used. Stent implantation
(self-expanding non-covered metal stent (SMART niti-
nol stent, Cordis, Miami,. FL, USA or Wallstent Boston
Scientific Corp; Natick, MA, USA) was used in patients
with recurrent stenosis. Brachytherapy was used when a
p a t i e n tr e q u i r e d3o rm o r einterventions within 6
months due to recurrent granulation tissue formation In
cases of recurrent refractory granulation tissue around a
metal stent placed for restoration of airway patency,
High-dose rate (HDR) endobronchial brachytherapy and
single application of a total 10 Gy was administrated
along the stent using a brachytherapy remote afterloader
with a
192Ir source as previously described [16].
If re-stenosis occurred on a follow up bronchoscopy
(usually every 4 to 6 weeks for the first 6 months) then
another intervention was applied.
Patients were considered cured when free of symp-
toms for at least one year after the last interventional
procedure. Statistical analysis Descriptive data are pre-
sented as mean (± SD) or median (range). Survival
curves were evaluated by the Kaplan-Meier method. Sta-
tistical analyses were performed using a statistical soft-
ware package (MedCalc Version 9.3.0.0, USA).
Results
A total of 115 patients (65 males and 50 women) with a
median age of 61 (range 40-88)Were identified between
January 2001 and January 2009. All patients presented
with signs and symptoms of upper airway obstruction
including shortness of breath, stridor, cough, dyspnea
and wheezing, and presented with typical flow volume
curve that demonstrate fixed airway obstruction The
etiologies for BTS are presented on Table 1. The vast
majority of patients had BTS following mechanical ven-
tilation through endotracheal tube (N = 76) or tra-
cheostomy (N = 30). The remaining patients had
Wegener’s granulomatosis, Sarcoidosis, amyloidosis and
idiopathic BTS. The morphologic characteristics of the
lesions are described on Table 2. Most patients had sig-
nificant co-morbidities and the most common were con-
gestive heart failure (N = 36) and chronic obstructive
lung disease (N = 34), nine patients had non-respiratory
tract malignancy. A total of 760 endoscopic procedures
(a mean of 6 procedures per patient) were performed.
The median duration of the procedure was 37 minutes(
range 14-45 minutes). All patients underwent balloon
dilatation as an initial temporary relieving procedure.
There were 460 sessions of laser treatment in 98
patients, of whom 58 patients required only laser photo-
resection without a need for another treatment modal-
ities (Figure 1). A total of 33 patients, all of them had
BTS due to previous mechanical ventilation through
endotracheal tube, underwent stent insertion (Figure 2),
of whom 28 underwent brachytherapy for prevention of
granulation tissue re-formation. All patients experienced
a reduction in therapeutic bronchoscopic procedures
after HDR brachytherapy compared with the pretreat-
ment period, there were no treatment related complica-
tions. All 85 patients who presented without post-
tracheostomy stenosis reported subjective relief. Out of
30 patients who presented with post-tracheostomy tra-
cheal stenosis, 15 (50%) underwent successful de-cannu-
lation. The overall success rate was 87%.
There were no intraoperative and peri-operative
deaths. Procedure complications were relatively minor
and manageable and included granulation tissue forma-
tion that required recurrent laser treatments (N = 30),
and tracheoesophegial fistula (N = 1). We obsereved no
other complication as stent fracture or a patient in
whom replacement of the stent was required. Over a
median follow-up of 51 months (range 10-100 months),
Table 1 Underlining etiologies for benign tracheal
stenosis among study subjects
POST MECHANICAL
VENTILATION (N = 106)
OTHER ETIOLOGIES (N = 9)
CHF (24) Sarcoidosis (1)
COPD (22) WG (2)
COPD & CHF (12) Amyloidosis (1)
Multiple trauma (11) Post laryngeal surgery (1)
Pneumonia (10) Idiopathic (4)
Malignancy (9)
Other (18)
Abbreviations: CHF: congestive heart failure; COPD:chronic obstructive lung
disease; WG: Wegener’s granulomatosis
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Page 2 of 530 patients (26%) died. Timing from the first interven-
tion to death ranged from 1 day to 6 years. The causes
of death were: Sepsis (N = 24), CHF (N = 8), broncho-
pleural fistula (N = 1), COPD (N = 3), pneumonia (N =
3), and malignancy (N = 4). As can be seen, most death
cases were due to exacerbation of the underlying condi-
tion and not directly related to the interventional proce-
dure. Cumulative survival rates at 1, 2, and 5 years were
80%, 73%, and 62% respectively (Figure 3).
Discussion
Surgical resection and end-to-end anastomosis is still
considered to be the optimal treatment for a young
patient presenting with symptomatic BTS [5,6]. For
elderly subjects or for patients with significant underlin-
ing co-morbidities, endoscopic treatment should be
considered [4]. In the current large case series we have
shown that bronchoscopic treatment modalities can pro-
vide durable successful results in selected patients with
BTS with a relatively low rate of complications. Previous
works [7-15] have discussed the bronchoscopic manage-
ment of BTS and reported similar success rates. Similar
to a previous smaller report [8], we noted that BTS after
endotracheal intubation and after tracheostomy differ in
t h es u c c e s sr a t e so fa i r w a yr estoration. The relatively
low success rate of de-cannulation reflects the different
pathophysiological mechanism for their formation [8].
BTS that occurs at the endotracheal tube cuff site
appears as web-like fibrous growth, due to Ischemic
damage and fibrotic healing process. On the other hand,
BTS following tracheostomy often involves apart from
granulation tissue formation also cartilage damage and
malacia. This difference may account for the difference
in the excellent results we obtained in post -intubation
BTS and the relatively disappointing outcome in post-
tracheostomy BTS. Another explanation lies in the
notion that patients who could not be weaned from
mechanical ventilation and had to be switched from
endotracheal tube to tracheostomy represent sub-group
of patients who are considerably sicker. The difficulties
in de-cannulation following endobronchial treatment
also stem fron their general health condition and co-
morbidities.
Table 2 The morphologic characteristics of the tracheal
lesion treated
LOCATION TYPE LENGTH DEGREE OF
STENOSIS
Subglottic (81) Web-like (97) < 1 cm (12) < 30% (4)
Upper trachea
(30)
Complex (18) 1-3 cm (99) 30-50% (57)
Mid and lower
trachea (4)
> 3 cm (4) 50-99%(56)
Figure 1 P o s t - i n t u b a t i o nb e n i g nt r a c h e a ls t e n o s i si na7 8 - y e a ro l dpatient who was mechanically ventilated for 10 days due to
chronic-obstructive lung disease. Concentric web-like tracheal obstruction before (a) and after (b) Nd-YAG laser resection and balloon
dilatation.
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Page 3 of 5Figure 2 Post-tracheostomy benign tracheal stenosis in a 56-year old female patient who was mechanically ventilated for 67 days
following multiple trauma. Concentric web-like tracheal obstruction before (a) and after (b) Nd-YAG laser resection balloon dilatation, and self-
expanding metallic stent placement.
Figure 3 Kaplan-Meyer survival analysis of study patients following the first bronchoscopic intervention.
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eral aspects that should be addressed. First, we employed
only flexible bronchoscope-based modalities and did not
use as in most previous works [3,4,8-15], rigid broncho-
scopy. The advantages of rigid bronchoscopy in treating
BTS are well known and include airway safety, the ability
to perform mechanical debulking, and the ease of blood
and airway secretion cleaning. The major drawbacks are
the need for operating room, anesthesiologist. and gen-
eral anesthesia that are obviated by the use of flexible
bronchoscopy under conscious sedation. We observed no
major intra-operative complication and feel that BTS
treatment can be safely and cost-effectively carried out in
the bronchoscopy suite by an experienced team. Given
the fact that all patients in whom a stent was required
had sub-glottic stenosis we preferred not to use silicone
stents. When a straight-type Dumon silicone stent is
placed in the subglottic trachea, movement of the head
and neck or coughing tend to induce stent migration [3].
The other unique aspect of the current report is the use
of HDR brachytherapy to treat and prevent recurrent
refractory granulation tissue formation around a metal
stent placed for restoration of airway patency following
lumen restoration in BTS. Previous works focused on the
use of corticosteroids injections and Mitomycin-C appli-
cations for treatment of reccurent refractory granulation
tissue formation and stenosis following treatment of BTS
are [3,4]. HDR endobronchial brachytherapy is widely
used as a palliative measure to overcome mechanical
obstruction of major airways caused by either primary or
secondary malignant tumors. It allows the delivery of a
high dose of radiation over a short period of time to the
obstructed area, and at the same time reducing the risk
of undesired side effects to adjacent structures. Our
group was the first [16] followed by others [17] to
describe the use of High-dose rate (HDR) endobronchial
brachytherapy to prevent and treat stent granulation in
benign conditions. In the current series HDR brachyther-
apy was successfully employed in 28 patients who had
refractory metal stent stenosis due to granulation tissue
formation. underwent brachytherapy for prevention of
granulation tissue re-formation. As more experience is
gained with this approach, we believe that the use of
endobronchial HDR brachytherapy will widely expand.
The procedure is safe, particularly in patients for whom
surgical mortality is by far more harmful. We believe that
this method should be used whenever a metal stent
placed for BTS is complicated by recurrent granulation
tissue growth.
Conclusion
Most cases of BTS in elderly subjects with co-morbid-
ities can be safely and effectively treated by flexible
bronchoscopic treatment modalities. The use of HDR
brachytherapy to prevent and treat granulation tissue
formation following successful airway restoration in
these cases is promising but should be further explored.
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